Deferred Revascularization Tied to Poor Outcomes in Diabetes
Previous MI is effect modifier for patients with FFR-negative medically treated lesions
Blocking Ceramide Production Might Prevent Type 2 Diabetes
Ceramides may impact way the body handles nutrients and responds to insulin
Part D Has Reduced Out-of-Pocket Rx Drug Costs in Diabetes
Decrease in proportion of Part D beneficiaries who experienced coverage gap to 40.9 percent in 2011
Many Obese Patients Are Lacking Formal Diagnosis
Less than 50 percent of those with a BMI >30 kg/m² have ICD-9 documentation for obesity
Half of Americans Have at Least One Chronic Health Condition
Medical conditions, mental illness, and substance abuse problems often overlap
Health Professionals View Insurance As Solution in Obesity
Fifty-seven percent perceive improved coverage as a solution to improve outcomes in obese patients
Lower Anti-Müllerian Hormone Values for Endometriomas
Significant decline seen in ovarian reserve at one month following surgical excision of endometriomas
Bilateral Renal Denervation Normalizes Insulin Sensitivity
Normalization seen in obese canines, by reducing hepatic gluconeogenic genes, including G6Pase
Incidence of Statin-Associated T2DM Relatively Low
Diabetogenic impact of statins increases as fasting plasma glucose, triglycerides, and BMI increase
Impact of HbA1c, BMI Changes on Lipids Varies As Children Age
HbA1c, BMI have modest impact on LDL and non-HDL cholesterol levels, but not on HDL
